Current location:opinions >>
The cancer drugs that could improve survival rates if given to patients in the morning
opinions3People have gathered around
IntroductionGiving cancer patients immunotherapy early in the morning rather than in the afternoon could improve ...
Giving cancer patients immunotherapy early in the morning rather than in the afternoon could improve survival rates.
A study has found that people with terminal lung or skin cancers lived twice as long if they received immunotherapy drugs — which help the immune system destroy cancer cells — at the start of the day instead of after lunchtime.
The best results were seen in those treated at about 7.30am. They lived on average another two-and-a-half years.
The researchers who led the trial, published in the European Journal of Cancer, think this may be due to the immune system being more active very early in the day.
Previous studies found there are higher levels of immune cells circulating in the blood in the early morning.
Giving cancer patients immunotherapy early in the morning rather than in the afternoon could improve survival rates, a new study has found (Stock Image)
Immunotherapy drugs stop the proteins from binding to T-cells, effectively turning the immune system back on, enabling it to seek and destroy cancerous growths. Pictured: A graphic showing cancer cells
As well as fighting off viruses and bacteria, these can attack cancer cells.
It's thought this is due to the circadian rhythm — our body clock — getting the immune system ready to face any daytime threats from infectious agents, such as in food or transmitted via interacting with people around us.
READ MORE: Alarm over insulin shortage as Brits battling type 1 diabetes fear they'll 'die within days' without access to life-saving drug
AdvertisementImmunotherapy drugs, such as ipilimumab, pembrolizumab and nivolumab, have transformed cancer care in the UK over the past decade or so.
Since 2011 when the first immunotherapy drugs were licensed in the UK for the treatment of malignant melanoma (the most dangerous form of skin cancer), average survival time has risen from six months to five years or more.
Most of these drugs — which can cost up to £100,000 per patient per year — work by attaching to a protein called PD-L1, which is produced in large quantities by cancer cells.
The protein switches off T-cells, defender cells released by the immune system, rendering them unable to attack the cancer.
Immunotherapy drugs stop the proteins from binding to T-cells, effectively turning the immune system back on, enabling it to seek and destroy cancerous growths.
The theory is that giving immunotherapy at the start of the day would supercharge this response, as there are more T-cells circulating then.
This follows previous research that showed people given the flu vaccine early in the day produced much higher levels of antibodies than those given the jab later.
Again, the thinking is that the immune system is more active then, so responds much more vigorously to vaccines.
The researchers, from a number of bodies in France — including the PSL Research University in Paris — analysed data from 361 patients with lung or skin cancer that had spread and who were treated with immunotherapy drugs between 2015 and 2021.
Their survival rates were compared with the usual time each patient received treatment — most had roughly the same slot every week or two weeks.
The theory is that giving immunotherapy at the start of the day supercharges a person's immune response, as there are more T-cells then. Picture: Molecular model of an antibody
The results showed those treated before noon survived an average of 30 months; after that average survival was 15.9 months.
Earlier studies also involving the timing of cancer treatments reached similar conclusions.
Now two larger trials are under way in China and the U.S. to see if more lives could be saved just by giving drugs in the morning. The results are expected in the next couple of years.
Dr Pasquale Innominato, a cancer specialist at Ysbyty Gwynedd Hospital in Bangor, Wales, who is also researching the effect of earlier drug delivery, said the findings have the potential to shake-up NHS patient care.
'We need to see results from the bigger trials, but all the evidence so far shows that, whatever type of immunotherapy drug is used and whatever type of cancer it is, there are benefits from giving treatment earlier in the day.'
Tags:
Reprint:Friends are welcome to share on the Internet, but please indicate the source of the article when reprinting it.“Stellar Space news portal”。http://honduras.chongwenmenhotelbeijing.com/html-73c998962.html
Related articles
Ben Whishaw lights up the Croisette as he joins his co
opinionsBen Whishaw was all smiles at the world premiere of Limonov: The Ballad at the 77th annual Cannes Fi ...
【opinions】
Read moreAsian American, Pacific Islander consumers want better brand representation, Nielsen reports
opinionsAs companies around the country roll out plans to honor May as Asian American, Native Hawaiian and P ...
【opinions】
Read moreLightning coach Jon Cooper apologizes for inappropriate comment about putting skirts on goalies
opinionsTAMPA, Fla. (AP) — Tampa Bay Lightning coach Jon Cooper opened his end-of-season news conference Wed ...
【opinions】
Read more
Popular articles
- Judge orders man accused of opening fire outside Wrigley Field held without bail
- New US sanctions against Russia target weapons development, ban uranium imports for nuclear power
- Kim Kardashian shows off her curves and continues to plug controversial $60k Cybertruck
- Jessica Simpson, 43, is a pretty pinup in a low
- Scottie Scheffler's Louisville court date postponed after arrest during PGA Championship
- Small ranching community tears itself apart as newly
Latest articles
Abbey Clancy, 38, shows off a new set of train track braces as she's left red
Hurricanes avoid major injury for DeAngelo and close in on getting Pesce back for Rangers series
Sarah Snook steps out with her mother and husband to watch her former Succession co
Georgia governor signs law requiring jailers to check immigration status of prisoners
Sophie Morgan suddenly quits ITV show Loose Women as she reveals plans for emigration
Jennifer Connelly wears Louis Vuitton ski
LINKS
- News organizations have trust issues as they gear up to cover another election, a poll finds
- Paul Auster, prolific and experimental man of letters and filmmaker, dies at 77
- Ryan Gosling, Mikey Day reprise Beavis and Butt
- Stock market today: Global stocks are mixed after Wall St tumble. Most markets close for holiday
- Tottenham manager Postecoglou jokes he's moving to Sweden for a life without VAR
- Here are the top American cities Joe Biden is sending hundreds of thousands of paroled migrants
- NATO chief chides allies for not being quicker to help Ukraine
- An Alabama Senate committee votes to reverse course, fund summer food program for low
- Hainault stabbing: The police who put their lives at risk to stop sword
- MICHAEL MOSLEY: How ultra